Monitoring of Oxidative Stress in Nurses Occupationally Exposed to Antineoplastic Drugs

Jump To References Section

Authors

  • M. Mahboob
     ,IN
  • M. F. Rahman
     ,IN
  • P. V. Rekhadevi
     ,IN
  • N. Sailaja
     ,IN
  • A. Balasubramanyam
     ,IN
  • P. V. Prabhakar
     ,IN
  • Shailendra Pratap Singh
     ,IN
  • Utkarsh A. Reddy
     ,IN
  • G. Sankara Rao
     ,IN
  • Paramjit Grover
     ,IN

Keywords:

Antineoplastic drugs, antioxidant, nurses, oxidative stress

Abstract

Antineoplastic drugs (ANDs) have been in clinical usage for more than five decades. The nonselective mechanism of action of ANDs between cancerous and noncancerous cells had well documented side effects such as acute symptoms, reproductive health issues, and potential cancer development in healthcare workers as a result of occupational exposure. The anticancer mechanism of ANDs is the generation of reactive oxygen species (ROS) which are responsible for various side effects in patients undergoing chemotherapy and the healthcare personnel occupationally exposed to them. ROS have potential to damage lipids, DNA, proteins, and so on leading to oxidative stress condition. The aim of this study was to evaluate the possible oxidative stress effect of antineoplastic drugs in nurses who routinely handle ANDs in an oncology hospital in south India. Malondialdehyde levels, reduced glutathione content, and glutathione S-transferase activity were analyzed in serum collected from 60 female nurses handling ANDs and compared with equal number of healthy volunteers matched by age and sex except AND exposure. The results showed statistically significant (P < 0.05) increase in malondialdehyde levels in the serum of exposed nurses. However, glutathione content and glutathione S-transferase activity was significantly decreased in these nurses. Our study suggests that the nurses occupationally exposed to ANDs were susceptible to the oxidative stress and emphasizes the need for a harmonized safe handling approach that assures minimal risk to the working nurses.

Downloads

Download data is not yet available.

Downloads

Published

2018-08-21

How to Cite

Mahboob, M., Rahman, M. F., Rekhadevi, P. V., Sailaja, N., Balasubramanyam, A., Prabhakar, P. V., Singh, S. P., Reddy, U. A., Rao, G. S., & Grover, P. (2018). Monitoring of Oxidative Stress in Nurses Occupationally Exposed to Antineoplastic Drugs. Toxicology International, 19(1), 20–24. Retrieved from https://www.informaticsjournals.com/index.php/toxi/article/view/21839

Issue

Volume 19, Issue 1, January- April 2012

Section

Original Research
Received 2018-08-21
Accepted 2018-08-21
Published 2018-08-21

 

References

Mader RM, Kokalj A, Kratochvil E, Pilger A, Rüdiger HW. Longitudinal biomonitoring of nurses handling antineoplastic drugs. J Clin Nurs 2008;18:263-9.

Baykal U, Seren S, Sokmen S. A description of oncology nurses' working conditions in Turkey. Eur J Oncol Nurs 2009;13:368-75.

Martin S. The adverse health effects of occupational exposure to hazardous drugs. Commun Oncol 2005;2:397-400.

Cavallo D, Ursini CL, Perniconi B, Francesco AD, Giglio M, Rubino FM, et al. Evaluation of genotoxic effects induced by exposure to antineoplastic drugs in lymphocytes and exfoliated buccal cells of oncology nurses and pharmacy employees. Mutat Res 2005;587:45-51.

Rekhadevi PV, Sailaja N, Chandrasekhar M, Mahboob M, Rahman MF, Grover P. Genotoxicity assessment in oncology nurses handling anti-neoplastic drugs. Mutagenesis 2007;22:395-401.

Undeğer U, Başaran N, Kars A, Güç D. Assessment of DNA damage in nurses handling antineoplastic drugs by the alkaline COMET assay. Mutat Res 1999;439:277-85.

Cornetta T, Padua L, Testa A, Ievoli E, Festa F, Tranfo G, et al.Molecular biomonitoring of a population of nurses handling antineoplastic drugs. Mutat Res 2008;638:75-82.

Rombaldi F, Cassini C, Salvador M, Saffi J, Erdtmann B.Occupational risk assessment of genotoxicity and oxidative stress in workers handling anti-neoplastic drugs during a working week. Mutagenesis 2009;24:143-8.

Anetor JI, Yaqub SA, Anetor GO, Nsonwu AC, Adeniyi FA, Fukushima S. Mixed chemical-induced oxidative stress in occupational exposure in Nigerians. Afr J Biotechnol 2009;8:821-6.

Wills ED. Lipid peroxide formation in microsomes. Relation of hydroxylation to lipid peroxide formation. Biochem J 1969;113:333-41.

Ellman GL. Determination of sulfhydryl group. Arch Biochem Biophys 1959;82:70-4.

Habig WH, Pabst MJ, Jakoby WB. Glutathione S-transferase. The first enzymatic step in mercapturic acid formation. J Biol Chem 1974;249:7130-9.

Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin-phenol reagent. J Biol Chem 1951;193:265-75.

Connor TH, McDiarmid MA. Preventing occupational exposures to antineoplastic drugs in health care settings. CA Cancer J Clin 2006;56:354-65.

Fuchs J, Hengstler JG, Jung D, Hiltl G, Konietzko J, Oesch F. DNA damage in nurses handling antineoplastic agents. Mutat Res 1995;342:17-23.

Maluf SW, Erdtmann B. Evaluation of occupational genotoxic risk in a Brazilian hospital. Genet Mol Biol 2000;23:485-8.

Turci R, Sottani C, Ronchi A, Minoia C. Biological monitoring of hospital personnel occupationally exposed to antineoplastic agents. Toxicol Lett 2002;134:57-64.

Deng H, Zhang M, He J, Wu W, Jin L, Zheng W, et al. Investigating genetic damage in workers occupationally exposed to methotrexate using three genetic end-points. Mutagenesis 2005;20:351-7.

Yao X, Panichpisal K, Kurtzman N, Nugent K. Cisplatin nephrotoxicity: a review. Am J Med Sci 2007;334:115-24.

Halliwell OI, Aruoma T. DNA damage by oxygen-derived species: Its mechanism and measurement in mammalian systems. FEBS J 1991;281:9-19.

Dean RT, Gieseg S, Davies M. Reactive species and their accumulation on radical-damaged proteins. Trends Biochem Sci 1993;18:437-41.

Ames B, Shigenaga M, Hagen T. Oxidants, antioxidants, and the degenerative diseases of ageing. USA: Proceedings of the National Academy of Sciences; 1993. p. 7915-22.

Kidd PM. Glutathione: systemic protectant against oxidative and free radical damage. Altern Med Rev 1997;1:155-76.

Conklin KA. Chemotherapy-associated oxidative stress: impact on chemotherapeutic effectiveness. Integr Cancer Ther 2004;3:294-300.

Alexandre J, Nicco C, Chéreau C, Laurent A, Weill B, Goldwasser F, et al. Improvement of the therapeutic index of anticancer drugs by the superoxide dismutase mimic mangafodipir. J Natl Cancer Inst 2006;98:236-44.

Ramanathan B, Jan KY, Chen CH, Hour TC, Yu HJ, Pu YS. Resistance to paclitaxel is proportional to cellular total antioxidant capacity.Cancer Res 2005;65:8455-60.

Kawai Y, Nakao T, Kunimura N, Kohda Y, Gemba M. Relationship of intracellular calcium and oxygen radicals to Cisplatin-related renal cell injury. J Pharmacol Sci 2006;100:65-72.

Del Rio D, Stewart AJ, Pellegrini N. A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis 2005;15:316-28.

Testa A, Giachelia M, Palma S, Appolloni M, Padua L, Tranfo G, et al. Occupational exposure to antineoplastic agents induces a high level of chromosome damage. Lack of an effect of GST polymorphisms. Toxicol Appl Pharmacol 2007;223:46-55.

Noori S, Mahboob T. Protective role of sodium selenite on cisplatin induced oxidative and renal stress. J Basic Appl Sci 2008;4:5-12.

Pratibha R, Sameer R, Rataboli PV, Bhiwgade DA, Dhume CY. Enzymatic studies of cisplatin induced oxidative stress in hepatic tissue of rats. Eur J Pharmacol 2006;532:290-3.

Mansour HH, Hafez HF, Fahmy NM. Silymarin modulates Cisplatin-induced oxidative stress and hepatotoxicity in rats. J Biochem Mol Biol 2006;39:656-61.

Kasapović J, Pejić S, Stojiljković V, Todorović A, Radošević-Jelić L, Saićić ZS, et al. Antioxidant status and lipid peroxidation in the blood of breast cancer patients of different ages after chemotherapy with 5-fluorouracil, doxorubicin and cyclophosphamide. Clin Biochem 2010;43:1287-93.